MX2022004262A - Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas. - Google Patents
Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.Info
- Publication number
- MX2022004262A MX2022004262A MX2022004262A MX2022004262A MX2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A MX 2022004262 A MX2022004262 A MX 2022004262A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- enhancing health
- wellbeing
- enhancing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/105—Persulfides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Las composiciones, métodos y equipos descritos en la presente pueden formularse como un suplemento nutricional o un suplemento dietético. La composición descrita en la presente puede proporcionar nutrientes o compuestos que de otro modo no se consumirían en cantidades suficientes en una dieta normal, y pueden contribuir al bienestar físico y al bienestar emocional de un sujeto.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762479091P | 2017-03-30 | 2017-03-30 | |
US201762506475P | 2017-05-15 | 2017-05-15 | |
US201862632965P | 2018-02-20 | 2018-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022004262A true MX2022004262A (es) | 2022-05-06 |
Family
ID=63676925
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019011510A MX2019011510A (es) | 2017-03-30 | 2018-03-23 | Metodos y composiciones para mejorar la salud. |
MX2022004262A MX2022004262A (es) | 2017-03-30 | 2019-09-26 | Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019011510A MX2019011510A (es) | 2017-03-30 | 2018-03-23 | Metodos y composiciones para mejorar la salud. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200101041A1 (es) |
EP (1) | EP3600271A4 (es) |
JP (2) | JP2020512358A (es) |
CN (1) | CN110709069A (es) |
AU (2) | AU2018243694A1 (es) |
BR (1) | BR112019020554A2 (es) |
CA (1) | CA3057994A1 (es) |
GB (1) | GB2577810A (es) |
IL (1) | IL269642A (es) |
MX (2) | MX2019011510A (es) |
WO (1) | WO2018183115A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
US20210030777A1 (en) * | 2018-04-04 | 2021-02-04 | Vinsan Therapeutics Inc. | Topical formuations and instillates, kits, and methods for treating integumentary wounds, and uses thereof |
EP3793542A4 (en) * | 2018-05-14 | 2022-03-30 | Buzzelet Development And Technologies Ltd | TERPENE-ENRICHED CANNABINOID COMPOSITIONS AND THEIR USES IN THE TREATMENT OF INFECTIOUS DISEASES |
CA3119729A1 (en) | 2018-10-10 | 2020-04-16 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
WO2020084450A1 (en) * | 2018-10-23 | 2020-04-30 | Radient Technologies Innovations Inc. | Method of automating cannabis decarboxylation and extraction by recursive decarboxylation, sampling, and extraction steps |
WO2020084425A1 (en) * | 2018-10-24 | 2020-04-30 | Radient Technologies Innovations Inc. | Side effect and symptom relief |
US10959961B2 (en) * | 2018-12-14 | 2021-03-30 | Natural Extraction Systems, LLC | Methods of administering anionic cannabinoid molecules dissolved in water |
US10609944B1 (en) | 2018-12-14 | 2020-04-07 | Natural Extraction Systems, LLC | Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol |
CA3138008A1 (en) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
US11622956B1 (en) | 2019-06-26 | 2023-04-11 | RCR BioPharma | Compound and method for treating diseases and disorders |
WO2021016710A1 (en) * | 2019-07-30 | 2021-02-04 | Tassili Life Sciences, Corp. | Controlled release formulations of multiple active pharmaceutical agents, and psilocybe-derived agents in combination with cannabis-derived agents and methods for their use |
US10780075B1 (en) * | 2019-07-31 | 2020-09-22 | Etain IP, LLC | Water soluble cannabis composition |
WO2021051105A2 (en) | 2019-09-12 | 2021-03-18 | Nulixir Inc. | Controlled release core-shell particles and suspensions including the same |
US20220362319A1 (en) * | 2021-05-12 | 2022-11-17 | PPM Labs LLC | Cannabinoid Concentration Process |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2400319B (en) * | 2001-05-04 | 2005-06-08 | Gw Pharma Ltd | Cannabinoid-rich extracts |
US8642645B2 (en) * | 2011-05-20 | 2014-02-04 | Brooks Kelly Research, LLC. | Pharmaceutical composition comprising Cannabinoids |
CA2904968A1 (en) * | 2013-03-14 | 2014-10-02 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
KR20160094950A (ko) * | 2013-10-31 | 2016-08-10 | 풀 스펙트럼 래버러토리즈, 리미티드 | 테르펜 및 칸나비노이드 제제 |
CA2965493C (en) * | 2014-10-21 | 2021-12-07 | United Cannabis Corp. | Cannabis extracts and methods of preparing and using same |
CA2974292C (en) | 2015-01-31 | 2024-04-16 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
WO2016138505A1 (en) * | 2015-02-27 | 2016-09-01 | Ebbu, LLC | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral |
US9747740B2 (en) * | 2015-03-02 | 2017-08-29 | Ford Global Technologies, Llc | Simultaneous button press secure keypad code entry |
CN109152748A (zh) * | 2016-05-06 | 2019-01-04 | 哈维斯特·迪莱科特企业有限公司 | 口服***药物的制造方法、组合物和医学应用 |
IL296008B1 (en) * | 2016-08-03 | 2024-05-01 | Zelira Therapeutics Operations Pty Ltd | Cannabis compound |
US20180344786A1 (en) * | 2017-06-06 | 2018-12-06 | NC3 Systems | System and method enhanced cannabiniod effect delivery |
CA3072519A1 (en) * | 2017-09-28 | 2019-04-04 | Canopy Growth Corporation | Edible cannabinoid compositions |
-
2018
- 2018-03-23 GB GB1914076.3A patent/GB2577810A/en not_active Withdrawn
- 2018-03-23 CN CN201880036367.5A patent/CN110709069A/zh active Pending
- 2018-03-23 AU AU2018243694A patent/AU2018243694A1/en active Pending
- 2018-03-23 JP JP2019553179A patent/JP2020512358A/ja not_active Withdrawn
- 2018-03-23 EP EP18775144.1A patent/EP3600271A4/en active Pending
- 2018-03-23 CA CA3057994A patent/CA3057994A1/en active Pending
- 2018-03-23 BR BR112019020554A patent/BR112019020554A2/pt unknown
- 2018-03-23 MX MX2019011510A patent/MX2019011510A/es unknown
- 2018-03-23 WO PCT/US2018/024061 patent/WO2018183115A1/en unknown
-
2019
- 2019-09-25 IL IL26964219A patent/IL269642A/en unknown
- 2019-09-26 MX MX2022004262A patent/MX2022004262A/es unknown
- 2019-09-27 US US16/585,630 patent/US20200101041A1/en active Pending
-
2023
- 2023-08-03 JP JP2023127414A patent/JP2023139315A/ja active Pending
-
2024
- 2024-05-21 AU AU2024203369A patent/AU2024203369A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3600271A1 (en) | 2020-02-05 |
AU2024203369A1 (en) | 2024-06-06 |
BR112019020554A2 (pt) | 2020-04-28 |
JP2020512358A (ja) | 2020-04-23 |
US20200101041A1 (en) | 2020-04-02 |
GB201914076D0 (en) | 2019-11-13 |
IL269642A (en) | 2019-11-28 |
AU2018243694A1 (en) | 2019-10-17 |
JP2023139315A (ja) | 2023-10-03 |
CN110709069A (zh) | 2020-01-17 |
CA3057994A1 (en) | 2018-10-04 |
WO2018183115A1 (en) | 2018-10-04 |
GB2577810A (en) | 2020-04-08 |
MX2019011510A (es) | 2020-01-09 |
EP3600271A4 (en) | 2020-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022004262A (es) | Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas. | |
MY192839A (en) | Multi-supplement compositions | |
PH12015501688A1 (en) | Nutritional compositions containing magnesium threonate and uses thereof | |
IN2012DN00282A (es) | ||
MX2016011898A (es) | Composiciones de compuestos selenoorganicos y metodos de uso de los mismos. | |
PH12016502368A1 (en) | Potato based protein mixtures and nutritional compositions comprising potato protein | |
MX2013005406A (es) | Composicion nutricional adaptada a la edad con grasas animales y grasas vegetales. | |
PH12018500994A1 (en) | Nutritional compositions containing butyrate and uses thereof | |
MX2015015628A (es) | Acido graso del aceite de bogol para uso en suplementos y composiciones de tratamiento y piensos para animales. | |
MX2018015731A (es) | Ingredientes de pienso que comprenden celulas microbianas lisadas. | |
MX2013012136A (es) | Composiciones que comprenden un antimetabolito de glucosa y selenio. | |
PH12019550209A1 (en) | A nutritional composition for use to enhance attention and/or reduce impulsivity | |
MX2017010852A (es) | Suplementos naturales enriquecidos por minerales. | |
PH12017500203A1 (en) | Nutritional composition for use in promoting gut and/or liver maturation and/or repair | |
MX2016007558A (es) | Un sistema de nutricion adaptado a la edad de un infante. | |
MY179829A (en) | Anti-regurgitation nutritional composition | |
SG11201901114TA (en) | Plant, method for producing plant, tolerance imparting method, tomato and method for producing tomato | |
PH12016501947A1 (en) | Gender specific synthetic nutritional compositions and nutritional systems comprising them | |
PH12019502354A1 (en) | Composition containing a chloride salt for use in pregnant animals | |
EA201992271A1 (ru) | Способы и композиции для улучшения здоровья | |
PH22017001036U1 (en) | Food supplement for the nervous system | |
MX2021010210A (es) | Una composicion nutricional para usar para mejorar la funcion ejecutiva. | |
ES2571427A1 (es) | Productos lácteos enriquecidos con clorela y espirulina | |
GB2528406A (en) | Prebiotic composition and method of its use | |
MX2019004082A (es) | Composiciones farmaceuticas para incrementar el deseo sexual en hombres. |